NDC Package 61958-2005-1 Descovy
Emtricitabine And Tenofovir Alafenamide Tablet Oral - View Billable Units, 11-Digit Format, RxNorm
Package Information
Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.
- RxCUI: 1747691 - emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet
- RxCUI: 1747697 - Descovy 200 MG / 25 MG Oral Tablet
- RxCUI: 1747697 - emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet [Descovy]
- RxCUI: 1747697 - Descovy (emtricitabine 200 MG / tenofovir alafenamide 25 MG) Oral Tablet
- RxCUI: 2590641 - emtricitabine 120 MG / tenofovir alafenamide 15 MG Oral Tablet
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor - [EPC] (Established Pharmacologic Class)
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor - [EPC] (Established Pharmacologic Class)
- Nucleoside Reverse Transcriptase Inhibitors - [MoA] (Mechanism of Action)
- Nucleosides - [CS]
- 61958 - Gilead Sciences, Inc.
- 61958-2005 - Descovy
- 61958-2005-1 - 30 TABLET in 1 BOTTLE, PLASTIC
- 61958-2005 - Descovy
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the disclaimer below.
NDC HCPCS Crosswalk
This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.
NDC 61958-2005-1 HCPCS crosswalk information with package details and bill units information.
| NDC Billing Code | HCPCS Code | HCPCS Code Desc. | Dosage | Package Size | Package Quantity | Billable Units | Billable Units / Pkg |
|---|---|---|---|---|---|---|---|
| 61958200501 | J0751 | EMTRICITABINE 200MG AND TENOFOVIR ALAFENAMIDE 25MG, ORAL, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT OF HIV) | 200 MG | 30 | EA |
* Please review the disclaimer below.
Frequently Asked Questions
What is NDC 61958-2005-1?
The NDC Packaged Code 61958-2005-1 is assigned to a package of 30 tablet in 1 bottle, plastic of Descovy, a human prescription drug labeled by Gilead Sciences, Inc.. The product's dosage form is tablet and is administered via oral form.
Is NDC 61958-2005 included in the NDC Directory?
Yes, Descovy with product code 61958-2005 is active and included in the NDC Directory. The product was first marketed by Gilead Sciences, Inc. on January 07, 2022 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.
What is the NDC billing unit for package 61958-2005-1?
The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.
What is the 11-digit format for NDC 61958-2005-1?
The 11-digit format is 61958200501. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.
This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:
| 10-Digit Format | 10-Digit Original Code | 11-Digit Format | 11-Digit Code |
|---|---|---|---|
| 5-4-1 | 61958-2005-1 | 5-4-2 | 61958-2005-01 |